Literature DB >> 6409241

Oxidative haemolysis after administration of doxorubicin.

D C Doll.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1983        PMID： 6409241      PMCID： PMC1548638          DOI： 10.1136/bmj.287.6386.180-a

Source DB:  PubMed          Journal:  Br Med J (Clin Res Ed)        ISSN： 0267-0623


× No keyword cloud information.
  5 in total

1.  Procabazine induced oxidative haemolysis: relationship in vivo red cell survival.

Authors:  R W Sponzo; J C Arseneau; G P Canellos
Journal:  Br J Haematol       Date:  1974-08       Impact factor: 6.998

2.  The effect of BCNU and adriamycin on normal and G6PD deficient erythrocytes.

Authors:  A L Sagone; G M Burton
Journal:  Am J Hematol       Date:  1979       Impact factor: 10.047

3.  Adriamycin and daunomycin generate reactive oxygen compounds in erythrocytes.

Authors:  C A Henderson; E N Metz; S P Balcerzak; A L Sagone
Journal:  Blood       Date:  1978-11       Impact factor: 22.113

4.  Clinical implications of sickle-cell trait and glucose-6-phosphate dehydrogenase deficiency in hospitalized black male patients.

Authors:  P Heller; W R Best; R B Nelson; J Becktel
Journal:  N Engl J Med       Date:  1979-05-03       Impact factor: 91.245

5.  Erythrocytotoxicity induced by cancer chemotherapeutic agents. In vitro studies of osmotic fragility and methaemoglobin generation.

Authors:  R D Barr; A R Davidson; L K Jung; K R Mohan Pai
Journal:  Scand J Haematol       Date:  1980-10
  5 in total
  2 in total

1.  No evidence that G6PD deficiency affects the efficacy or safety of daunorubicin in acute lymphoblastic leukemia induction therapy.

Authors:  Katherine M Robinson; Wenjian Yang; Seth E Karol; Nancy Kornegay; Dennis Jay; Cheng Cheng; John K Choi; Dario Campana; Ching-Hon Pui; Brent Wood; Michael J Borowitz; Julie Gastier-Foster; Eric C Larsen; Naomi Winick; William L Carroll; Mignon L Loh; Elizabeth A Raetz; Stephen P Hunger; Meenakshi Devidas; Elaine R Mardis; Robert S Fulton; Mary V Relling; Sima Jeha
Journal:  Pediatr Blood Cancer       Date:  2019-03-07       Impact factor: 3.167

2.  Treatment of a patient with breast cancer and glucose 6-phosphate dehydrogenase deficiency: A case report.

Authors:  Wei-Pang Chung; Ya-Tin Hsu; Ya-Ping Chen; Hui-Ping Hsu
Journal:  Medicine (Baltimore)       Date:  2019-03       Impact factor: 1.889
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.